Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Capital Leases (2024 - 2025)

Exagen (XGN) has disclosed Capital Leases for 2 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Leases rose 1148.41% year-over-year to $2.0 million, compared with a TTM value of $2.0 million through Dec 2025, up 1148.41%, and an annual FY2025 reading of $2.0 million, up 1148.41% over the prior year.
  • Capital Leases was $2.0 million for Q4 2025 at Exagen, down from $2.1 million in the prior quarter.
  • Across five years, Capital Leases topped out at $2.1 million in Q3 2025 and bottomed at $157000.0 in Q4 2024.